Abciximab
Diclofenac may increase the anticoagulant activities of Abciximab.
Abiraterone
The serum concentration of Diclofenac can be increased when it is combined with Abiraterone.
Acebutolol
Diclofenac may decrease the antihypertensive activities of Acebutolol.
Advertisement
Aceclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Aceclofenac.
Acemetacin
The risk or severity of adverse effects can be increased when Diclofenac is combined with Acemetacin.
Acenocoumarol
Diclofenac may increase the anticoagulant activities of Acenocoumarol.
Advertisement
Acetyl salicylate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Acetylsalicylic acid.
Aclarubicin
Diclofenac may decrease the excretion rate of Aclarubicin which could result in a higher serum level.
Adapalene
The risk or severity of adverse effects can be increased when Diclofenac is combined with Adapalene.
Advertisement
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Diclofenac.
Alclometasone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Alclometasone.
Aldosterone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Aldosterone.
Alendronate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.
Alendronic acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.
Aliskiren
Diclofenac may decrease the antihypertensive activities of Aliskiren.
Alminoprofen
The risk or severity of adverse effects can be increased when Diclofenac is combined with Alminoprofen.
Alprenolol
Diclofenac may decrease the antihypertensive activities of Alprenolol.
Alprostadil
The therapeutic efficacy of Alprostadil can be decreased when used in combination with Diclofenac.
Amcinonide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Amcinonide.
Amikacin
Diclofenac may decrease the excretion rate of Amikacin which could result in a higher serum level.
Amiloride
Diclofenac may decrease the antihypertensive activities of Amiloride.
Amiodarone
The serum concentration of Diclofenac can be increased when it is combined with Amiodarone.
Ancrod
Diclofenac may increase the anticoagulant activities of Ancrod.
Androstenedione
The risk or severity of adverse effects can be increased when Diclofenac is combined with Androstenedione.
Anhydrous Tacrolimus
Diclofenac may increase the nephrotoxic activities of Tacrolimus.
Antipyrine
The risk or severity of adverse effects can be increased when Diclofenac is combined with Antipyrine.
Antithrombin III
Diclofenac may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Diclofenac may increase the anticoagulant activities of Antithrombin III human.
Apalutamide
The serum concentration of Diclofenac can be decreased when it is combined with Apalutamide.
Apazone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Azapropazone.
Apixaban
Diclofenac may increase the anticoagulant activities of Apixaban.
Apremilast
The risk or severity of adverse effects can be increased when Diclofenac is combined with Apremilast.
Aprepitant
The serum concentration of Diclofenac can be increased when it is combined with Aprepitant.
Arbekacin
Diclofenac may decrease the excretion rate of Arbekacin which could result in a higher serum level.
Ardeparin
Diclofenac may increase the anticoagulant activities of Ardeparin.
Argatroban
Diclofenac may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Diclofenac may increase the anticoagulant activities of Argatroban.
Armodafinil
The metabolism of Diclofenac can be decreased when combined with Armodafinil.
Aspirin
The risk or severity of adverse effects can be increased when Diclofenac is combined with Acetylsalicylic acid.
Atazanavir
The metabolism of Diclofenac can be decreased when combined with Atazanavir.
Atenolol
Diclofenac may decrease the antihypertensive activities of Atenolol.
Atomoxetine
The metabolism of Diclofenac can be decreased when combined with Atomoxetine.
Azelastine
The risk or severity of adverse effects can be increased when Diclofenac is combined with Azelastine.
azficel-T
The risk or severity of adverse effects can be increased when Diclofenac is combined with Azficel-T.
Azilsartan
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Diclofenac.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Diclofenac.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Diclofenac.
Azithromycin
The metabolism of Diclofenac can be decreased when combined with Azithromycin.
Azosemide
The therapeutic efficacy of Azosemide can be decreased when used in combination with Diclofenac.
Balsalazide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Balsalazide.
Becaplermin
Diclofenac may increase the anticoagulant activities of Becaplermin.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Beclomethasone dipropionate.
Benazepril
The risk or severity of adverse effects can be increased when Diclofenac is combined with Benazepril.
Bendroflumethiazide
The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Diclofenac.
Benzydamine
The risk or severity of adverse effects can be increased when Diclofenac is combined with Benzydamine.
Betamethasone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Betamethasone.
Betaxolol
Diclofenac may decrease the antihypertensive activities of Betaxolol.
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Diclofenac.
Bimatoprost
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Diclofenac.
Bisoprolol
Diclofenac may decrease the antihypertensive activities of Bisoprolol.
Bivalirudin
Diclofenac may increase the anticoagulant activities of Bivalirudin.
Boceprevir
The metabolism of Diclofenac can be decreased when combined with Boceprevir.
Bopindolol
Diclofenac may decrease the antihypertensive activities of Bopindolol.
Bortezomib
The metabolism of Diclofenac can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Diclofenac can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Diclofenac.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Diclofenac.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Diclofenac.
Bromfenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Bromfenac.
Budesonide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Budesonide.
Bufexamac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Bufexamac.
Bumetanide
The therapeutic efficacy of Bumetanide can be decreased when used in combination with Diclofenac.
Bupranolol
Diclofenac may decrease the antihypertensive activities of Bupranolol.
Caffeine
The metabolism of Diclofenac can be decreased when combined with Caffeine.
Candesartan
The risk or severity of adverse effects can be increased when Candesartan is combined with Diclofenac.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Diclofenac.
Capecitabine
The serum concentration of Diclofenac can be increased when it is combined with Capecitabine.
Captopril
The risk or severity of adverse effects can be increased when Diclofenac is combined with Captopril.
Carbamazepine
The serum concentration of Diclofenac can be decreased when it is combined with Carbamazepine.
Carboprost
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Diclofenac.
Carboprost Tromethamine
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Diclofenac.
Carprofen
The risk or severity of adverse effects can be increased when Diclofenac is combined with Carprofen.
Carteolol
Diclofenac may decrease the antihypertensive activities of Carteolol.
Carvedilol
Diclofenac may decrease the antihypertensive activities of Carvedilol.
Celecoxib
The risk or severity of adverse effects can be increased when Diclofenac is combined with Celecoxib.
Celiprolol
Diclofenac may decrease the antihypertensive activities of Celiprolol.
Ceritinib
The serum concentration of Diclofenac can be increased when it is combined with Ceritinib.
Certoparin
Diclofenac may increase the anticoagulant activities of Certoparin.
Chloramphenicol
The metabolism of Diclofenac can be decreased when combined with Chloramphenicol.
Chloroquine
The risk or severity of adverse effects can be increased when Diclofenac is combined with Chloroquine.
Chlorothiazide
The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Diclofenac.
Chlorthalidone
The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Diclofenac.
Cholecalciferol
The metabolism of Diclofenac can be decreased when combined with Cholecalciferol.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Diclofenac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Choline magnesium trisalicylate.
Ciclesonide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Ciclesonide.
Cilazapril
The risk or severity of adverse effects can be increased when Diclofenac is combined with Cilazapril.
Cimetidine
The metabolism of Diclofenac can be decreased when combined with Cimetidine.
Cinoxacin
Diclofenac may increase the neuroexcitatory activities of Cinoxacin.
Citalopram
The metabolism of Diclofenac can be decreased when combined with Citalopram.
Citric Acid
Diclofenac may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Diclofenac may increase the anticoagulant activities of Citric Acid.
Clarithromycin
The metabolism of Diclofenac can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Diclofenac can be decreased when combined with Clemastine.
Clobetasol
The risk or severity of adverse effects can be increased when Diclofenac is combined with Clobetasol.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Clobetasol propionate.
Clobetasone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Clobetasone.
Clocortolone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Clocortolone.
Clodronic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Clodronic Acid.
Clofezone
The metabolism of Diclofenac can be decreased when combined with Rabeprazole.
Clonixin
The risk or severity of adverse effects can be increased when Diclofenac is combined with Clonixin.
Clopidogrel
The metabolism of Diclofenac can be decreased when combined with Clopidogrel.
Clotrimazole
The metabolism of Diclofenac can be decreased when combined with Clotrimazole.
Cobicistat
The metabolism of Diclofenac can be decreased when combined with Cobicistat.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Diclofenac.
Colesevelam
Colesevelam can cause a decrease in the absorption of Diclofenac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Diclofenac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Diclofenac.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Cortisone acetate.
Crisaborole
The metabolism of Diclofenac can be decreased when combined with Crisaborole.
Crizotinib
The metabolism of Diclofenac can be decreased when combined with Crizotinib.
Curcumin
The risk or severity of adverse effects can be increased when Diclofenac is combined with Curcumin.
Cyclopenthiazide
The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Diclofenac.
Cyclosporine
Diclofenac may increase the nephrotoxic activities of Cyclosporine.
Cyproterone Acetate
The serum concentration of Diclofenac can be decreased when it is combined with Cyproterone acetate.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Diclofenac.
Dabrafenib
The serum concentration of Diclofenac can be decreased when it is combined with Dabrafenib.
Dalteparin
Diclofenac may increase the anticoagulant activities of Dalteparin.
Danaparoid
Diclofenac may increase the anticoagulant activities of Danaparoid.
Darunavir
The metabolism of Diclofenac can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Diclofenac can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Diclofenac can be increased when it is combined with Dasatinib.
Daunorubicin
Diclofenac may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Deferasirox
The serum concentration of Diclofenac can be decreased when it is combined with Deferasirox.
Deflazacort
The risk or severity of adverse effects can be increased when Diclofenac is combined with Deflazacort.
Delavirdine
The serum concentration of Diclofenac can be increased when it is combined with Delavirdine.
Desipramine
The metabolism of Diclofenac can be decreased when combined with Desipramine.
Desirudin
Diclofenac may increase the anticoagulant activities of Desirudin.
Desmopressin
The risk or severity of adverse effects can be increased when Diclofenac is combined with Desmopressin.
Desonide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Desonide.
Desoximetasone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Desoximetasone.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Desoxycorticosterone acetate.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Desoxycorticosterone Pivalate.
Dexamethasone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Dexamethasone.
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Diclofenac.
Dextran
Diclofenac may increase the anticoagulant activities of Dextran.
Dextran 40
Diclofenac may increase the anticoagulant activities of Dextran 40.
Dextran 70
Diclofenac may increase the anticoagulant activities of Dextran 70.
Dextran 75
Diclofenac may increase the anticoagulant activities of Dextran 75.
Dicumarol
Diclofenac may increase the anticoagulant activities of Dicoumarol.
Diflorasone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Diflorasone.
Diflucortolone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Difluocortolone.
Diflunisal
The risk or severity of adverse effects can be increased when Diclofenac is combined with Diflunisal.
Difluprednate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Difluprednate.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Diclofenac.
Dihydroergotamine
The metabolism of Diclofenac can be decreased when combined with Dihydroergotamine.
Dihydrostreptomycin
Diclofenac may decrease the excretion rate of Dihydrostreptomycin which could result in a higher serum level.
Diltiazem
The metabolism of Diclofenac can be decreased when combined with Diltiazem.
Dinoprost
The therapeutic efficacy of Dinoprost can be decreased when used in combination with Diclofenac.
Dinoprost Tromethamine
The therapeutic efficacy of Dinoprost Tromethamine can be decreased when used in combination with Diclofenac.
Dinoprostone
The therapeutic efficacy of Dinoprostone can be decreased when used in combination with Diclofenac.
Dipyrone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Metamizole.
Dothiepin
The serum concentration of Diclofenac can be increased when it is combined with Dosulepin.
Doxorubicin
Diclofenac may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Doxorubicin Hydrochloride
Diclofenac may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Doxycycline
The metabolism of Diclofenac can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Diclofenac can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Diclofenac can be decreased when combined with Dronedarone.
Drospirenone
Diclofenac may increase the hyperkalemic activities of Drospirenone.
Droxicam
The risk or severity of adverse effects can be increased when Diclofenac is combined with Droxicam.
Edetic Acid
Diclofenac may increase the anticoagulant activities of Edetic Acid.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Diclofenac.
Efavirenz
The metabolism of Diclofenac can be decreased when combined with Efavirenz.
Enalapril
The risk or severity of adverse effects can be increased when Diclofenac is combined with Enalapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Diclofenac is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Diclofenac is combined with Enalaprilat.
Enoxacin
Diclofenac may increase the neuroexcitatory activities of Enoxacin.
Enoxaparin
Diclofenac may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Diclofenac may increase the anticoagulant activities of Enoxaparin.
Enzalutamide
The serum concentration of Diclofenac can be decreased when it is combined with Enzalutamide.
Epirubicin
Diclofenac may decrease the excretion rate of Epirubicin which could result in a higher serum level.
Eplerenone
Diclofenac may decrease the antihypertensive activities of Eplerenone.
Epoprostenol
The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Diclofenac.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Diclofenac.
Erythromycin
The metabolism of Diclofenac can be decreased when combined with Erythromycin.
Eslicarbazepine Acetate
The metabolism of Diclofenac can be decreased when combined with Eslicarbazepine acetate.
Esmolol
Diclofenac may decrease the antihypertensive activities of Esmolol.
Esomeprazole
The metabolism of Diclofenac can be decreased when combined with Esomeprazole.
Estrone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Estrone.
Etanercept
The risk or severity of adverse effects can be increased when Diclofenac is combined with Etanercept.
Ethacrynate
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Diclofenac.
Ethacrynic Acid
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Diclofenac.
Ethylenediaminetetraacetate
Diclofenac may increase the anticoagulant activities of Edetic Acid.
Etidronate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Etidronic acid.
Etidronic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Etidronic acid.
Etodolac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Etodolac.
Etofenamate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Etofenamate.
Etoricoxib
The risk or severity of adverse effects can be increased when Diclofenac is combined with Etoricoxib.
Etravirine
The metabolism of Diclofenac can be decreased when combined with Etravirine.
Evening primrose oil
The risk or severity of adverse effects can be increased when Diclofenac is combined with Evening primrose oil.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Diclofenac.
Felbinac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Felbinac.
Felodipine
The metabolism of Diclofenac can be decreased when combined with Felodipine.
Fenbufen
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fenbufen.
Fenoprofen
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fenoprofen.
Ferulic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Ferulic acid.
Fleroxacin
Diclofenac may increase the neuroexcitatory activities of Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Diclofenac.
Floxuridine
The serum concentration of Diclofenac can be increased when it is combined with Floxuridine.
Fluconazole
The serum concentration of Diclofenac can be increased when it is combined with Fluconazole.
Fludrocortisone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fludrocortisone.
Fluindione
Diclofenac may increase the anticoagulant activities of Fluindione.
Flumequine
Diclofenac may increase the neuroexcitatory activities of Flumequine.
Flumethasone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Flumethasone.
Flunisolide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Flunisolide.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Diclofenac is combined with Flunisolide.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fluocinolone Acetonide.
Fluocinonide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fluocinonide.
Fluocortolone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fluocortolone.
Fluorometholone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fluorometholone.
Fluorouracil
The serum concentration of Diclofenac can be increased when it is combined with Fluorouracil.
Fluoxetine
The metabolism of Diclofenac can be decreased when combined with Fluoxetine.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fluprednidene.
Fluprednisolone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fluprednisolone.
Flurandrenolide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Flurandrenolide.
Flurbiprofen
The risk or severity of adverse effects can be increased when Diclofenac is combined with Flurbiprofen.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fluticasone furoate.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fluticasone propionate.
Fluvastatin
The metabolism of Diclofenac can be decreased when combined with Fluvastatin.
Fluvoxamine
The metabolism of Diclofenac can be decreased when combined with Fluvoxamine.
Folate
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Diclofenac.
Folic Acid
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Diclofenac.
Fondaparinux
Diclofenac may increase the anticoagulant activities of Fondaparinux.
Fondaparinux sodium
Diclofenac may increase the anticoagulant activities of Fondaparinux sodium.
Formestane
The risk or severity of adverse effects can be increased when Diclofenac is combined with Formestane.
Fosamprenavir
The metabolism of Diclofenac can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Diclofenac can be increased when it is combined with Fosaprepitant.
Fosinopril
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fosinopril.
Fosphenytoin
The serum concentration of Diclofenac can be decreased when it is combined with Fosphenytoin.
Framycetin
Diclofenac may decrease the excretion rate of Framycetin which could result in a higher serum level.
Furosemide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Diclofenac.
Fusidate
The serum concentration of Diclofenac can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Diclofenac can be increased when it is combined with Fusidic Acid.
Gatifloxacin
Diclofenac may increase the neuroexcitatory activities of Gatifloxacin.
Gatifloxacin Anhydrous
Diclofenac may increase the neuroexcitatory activities of Gatifloxacin.
Gemeprost
The therapeutic efficacy of Gemeprost can be decreased when used in combination with Diclofenac.
Gemfibrozil
The serum concentration of Diclofenac can be increased when it is combined with Gemfibrozil.
Gemifloxacin
Diclofenac may increase the neuroexcitatory activities of Gemifloxacin.
Gemifloxacin Mesylate
Diclofenac may increase the neuroexcitatory activities of Gemifloxacin.
Gentamicin
Diclofenac may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Grepafloxacin
Diclofenac may increase the neuroexcitatory activities of Grepafloxacin.
Halcinonide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Halcinonide.
Halobetasol
The risk or severity of adverse effects can be increased when Diclofenac is combined with Ulobetasol.
Haloperidol
The risk or severity of adverse effects can be increased when Diclofenac is combined with Haloperidol.
Heparin
Diclofenac may increase the anticoagulant activities of Heparin.
Hydralazine
Diclofenac may decrease the antihypertensive activities of Hydralazine.
Hydrochlorothiazide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Diclofenac.
Hydrocortisone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Diclofenac.
Hypoxis hemerocallidea root extract
The serum concentration of Diclofenac can be decreased when it is combined with St. John's Wort.
Ibandronate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Ibandronate.
Ibandronic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Ibandronate.
Ibuprofen
The risk or severity of adverse effects can be increased when Diclofenac is combined with Ibuprofen.
Icatibant
The risk or severity of adverse effects can be increased when Diclofenac is combined with Icatibant.
Idarubicin
Diclofenac may decrease the excretion rate of Idarubicin which could result in a higher serum level.
Idelalisib
The metabolism of Diclofenac can be decreased when combined with Idelalisib.
Iloprost
The therapeutic efficacy of Iloprost can be decreased when used in combination with Diclofenac.
Imatinib
The metabolism of Diclofenac can be decreased when combined with Imatinib.
Imidapril
The risk or severity of adverse effects can be increased when Diclofenac is combined with Imidapril.
Indapamide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Diclofenac.
Indinavir
The metabolism of Diclofenac can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Diclofenac can be decreased when combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Diclofenac is combined with Indobufen.
Indomethacin
The risk or severity of adverse effects can be increased when Diclofenac is combined with Indomethacin.
Irbesartan
The metabolism of Diclofenac can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Diclofenac can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Diclofenac can be decreased when combined with Isavuconazonium.
Isoniazid
The metabolism of Diclofenac can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Diclofenac can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Diclofenac can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Diclofenac can be increased when it is combined with Ivacaftor.
Kanamycin
Diclofenac may decrease the excretion rate of Kanamycin which could result in a higher serum level.
kanamycin A
Diclofenac may decrease the excretion rate of Kanamycin which could result in a higher serum level.
Kebuzone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Kebuzone.
Ketoconazole
The metabolism of Diclofenac can be decreased when combined with Ketoconazole.
Ketoprofen
The risk or severity of adverse effects can be increased when Diclofenac is combined with Ketoprofen.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Diclofenac.
Labetalol
Diclofenac may decrease the antihypertensive activities of Labetalol.
Lapatinib
The metabolism of Diclofenac can be decreased when combined with Lapatinib.
Latanoprost
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Diclofenac.
Latanoprostene Bunod
The therapeutic efficacy of Latanoprostene Bunod can be decreased when used in combination with Diclofenac.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Diclofenac.
Leflunomide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Leflunomide.
Lepirudin
Diclofenac may increase the anticoagulant activities of Lepirudin.
Levobunolol
Diclofenac may decrease the antihypertensive activities of Levobunolol.
Levofloxacin
Diclofenac may increase the neuroexcitatory activities of Levofloxacin.
Levofloxacin Anhydrous
Diclofenac may increase the neuroexcitatory activities of Levofloxacin.
Lidocaine
The metabolism of Diclofenac can be decreased when combined with Lidocaine.
Limonene, (+)-
The risk or severity of adverse effects can be increased when Diclofenac is combined with (4R)-limonene.
Lisinopril
The risk or severity of adverse effects can be increased when Diclofenac is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Diclofenac is combined with Lisinopril.
Lithium
The serum concentration of Lithium can be increased when it is combined with Diclofenac.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Diclofenac.
Lopinavir
The metabolism of Diclofenac can be decreased when combined with Lopinavir.
Lornoxicam
The risk or severity of adverse effects can be increased when Diclofenac is combined with Lornoxicam.
Losartan
The metabolism of Diclofenac can be decreased when combined with Losartan.
Loteprednol
The risk or severity of adverse effects can be increased when Diclofenac is combined with Loteprednol.
Lovastatin
The metabolism of Diclofenac can be decreased when combined with Lovastatin.
Loxoprofen
The risk or severity of adverse effects can be increased when Diclofenac is combined with Loxoprofen.
Lubiprostone
The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Diclofenac.
Luliconazole
The serum concentration of Diclofenac can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Diclofenac can be increased when it is combined with Lumacaftor.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Magnesium salicylate.
Manidipine
The metabolism of Diclofenac can be decreased when combined with Manidipine.
Masoprocol
The risk or severity of adverse effects can be increased when Diclofenac is combined with Masoprocol.
Meclofenamate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Meclofenamic acid.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Meclofenamic acid.
Medronate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Technetium Tc-99m medronate.
Medrysone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Medrysone.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Mefenamic acid.
Meloxicam
The risk or severity of adverse effects can be increased when Diclofenac is combined with Meloxicam.
Mesalamine
The risk or severity of adverse effects can be increased when Diclofenac is combined with Mesalazine.
Methotrexate
The serum concentration of Methotrexate can be increased when it is combined with Diclofenac.
Methyclothiazide
The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Diclofenac.
Methylprednisolone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Methylprednisolone.
Metipranolol
Diclofenac may decrease the antihypertensive activities of Metipranolol.
Metolazone
The therapeutic efficacy of Metolazone can be decreased when used in combination with Diclofenac.
Metoprolol
Diclofenac may decrease the antihypertensive activities of Metoprolol.
Metrizamide
Diclofenac may decrease the excretion rate of Metrizamide which could result in a higher serum level.
Mexiletine
The metabolism of Diclofenac can be decreased when combined with Mexiletine.
Midostaurin
The serum concentration of Diclofenac can be increased when it is combined with Midostaurin.
Mifepristone
The serum concentration of Diclofenac can be increased when it is combined with Mifepristone.
Misoprostol
The therapeutic efficacy of Misoprostol can be decreased when used in combination with Diclofenac.
Mitotane
The serum concentration of Diclofenac can be decreased when it is combined with Mitotane.
Moclobemide
The metabolism of Diclofenac can be decreased when combined with Moclobemide.
Modafinil
The metabolism of Diclofenac can be decreased when combined with Modafinil.
Moexipril
The risk or severity of adverse effects can be increased when Diclofenac is combined with Moexipril.
Mometasone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Mometasone.
Morniflumate
The risk or severity of adverse effects can be increased when Morniflumate is combined with Diclofenac.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Diclofenac is combined with Mycophenolic acid.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Diclofenac is combined with Mycophenolate mofetil.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Mycophenolic acid.
Nabumetone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Nabumetone.
Nadolol
Diclofenac may decrease the antihypertensive activities of Nadolol.
Nadroparin
Diclofenac may increase the anticoagulant activities of Nadroparin.
Naftifine
The risk or severity of adverse effects can be increased when Diclofenac is combined with Naftifine.
Nalidixic Acid
Diclofenac may increase the neuroexcitatory activities of Nalidixic Acid.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Diclofenac.
Naproxen
The risk or severity of adverse effects can be increased when Diclofenac is combined with Naproxen.
Nebivolol
Diclofenac may decrease the antihypertensive activities of Nebivolol.
Nefazodone
The metabolism of Diclofenac can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Diclofenac can be decreased when combined with Nelfinavir.
Neomycin
Diclofenac may decrease the excretion rate of Neomycin which could result in a higher serum level.
Nepafenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Nepafenac.
Netilmicin
Diclofenac may decrease the excretion rate of Netilmicin which could result in a higher serum level.
Netupitant
The serum concentration of Diclofenac can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Diclofenac can be increased when combined with Nevirapine.
Nicardipine
The serum concentration of Diclofenac can be increased when it is combined with Nicardipine.
Niflumic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Niflumic Acid.
Nilotinib
The metabolism of Diclofenac can be decreased when combined with Nilotinib.
Nimesulide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Nimesulide.
Norfloxacin
Diclofenac may increase the neuroexcitatory activities of Norfloxacin.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Diclofenac is combined with Evening primrose oil.
Olaparib
The metabolism of Diclofenac can be decreased when combined with Olaparib.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Diclofenac.
Olopatadine
The risk or severity of adverse effects can be increased when Diclofenac is combined with Olopatadine.
Olsalazine
The risk or severity of adverse effects can be increased when Diclofenac is combined with Olsalazine.
Omacetaxine Mepesuccinate
The risk or severity of bleeding can be increased when Diclofenac is combined with Omacetaxine mepesuccinate.
Omeprazole
The metabolism of Diclofenac can be decreased when combined with Omeprazole.
Osimertinib
The serum concentration of Diclofenac can be increased when it is combined with Osimertinib.
Oxaprozin
The risk or severity of adverse effects can be increased when Diclofenac is combined with Oxaprozin.
Oxprenolol
Diclofenac may decrease the antihypertensive activities of Oxprenolol.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Oxyphenbutazone.
Palbociclib
The serum concentration of Diclofenac can be increased when it is combined with Palbociclib.
Pamidronate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Pamidronate.
Pamidronic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Pamidronate.
Pantoprazole
The metabolism of Diclofenac can be decreased when combined with Pantoprazole.
Paramethasone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Paramethasone.
Parecoxib
The risk or severity of adverse effects can be increased when Diclofenac is combined with Parecoxib.
Paromomycin
Diclofenac may decrease the excretion rate of Paromomycin which could result in a higher serum level.
Paroxetine
The metabolism of Diclofenac can be decreased when combined with Paroxetine.
Parthenolide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Parthenolide.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Diclofenac.
Pefloxacin
Diclofenac may increase the neuroexcitatory activities of Pefloxacin.
Peginterferon Alfa-2b
The serum concentration of Diclofenac can be increased when it is combined with Peginterferon alfa-2b.
Penbutolol
Diclofenac may decrease the antihypertensive activities of Penbutolol.
Pentaerythritol Tetranitrate
Diclofenac may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentobarbital
The metabolism of Diclofenac can be increased when combined with Pentobarbital.
Pentosan Polysulfate
Diclofenac may increase the anticoagulant activities of Pentosan Polysulfate.
Perindopril
The risk or severity of adverse effects can be increased when Diclofenac is combined with Perindopril.
Phenindione
Diclofenac may increase the anticoagulant activities of Phenindione.
Phenobarbital
The serum concentration of Diclofenac can be decreased when it is combined with Phenobarbital.
Phenprocoumon
Diclofenac may increase the anticoagulant activities of Phenprocoumon.
Phenylbutazone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Phenylbutazone.
Phenytoin
The serum concentration of Diclofenac can be decreased when it is combined with Phenytoin.
Pimecrolimus
The risk or severity of adverse effects can be increased when Diclofenac is combined with Pimecrolimus.
Pindolol
Diclofenac may decrease the antihypertensive activities of Pindolol.
Pioglitazone
The metabolism of Diclofenac can be decreased when combined with Pioglitazone.
Pirarubicin
Diclofenac may decrease the excretion rate of Pirarubicin which could result in a higher serum level.
Piretanide
The therapeutic efficacy of Piretanide can be decreased when used in combination with Diclofenac.
Pirfenidone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Pirfenidone.
Piroxicam
The risk or severity of adverse effects can be increased when Diclofenac is combined with Piroxicam.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Diclofenac is combined with Piroxicam.
Plicamycin
Diclofenac may decrease the excretion rate of Plicamycin which could result in a higher serum level.
Polythiazide
The therapeutic efficacy of Polythiazide can be decreased when used in combination with Diclofenac.
Posaconazole
The metabolism of Diclofenac can be decreased when combined with Posaconazole.
Practolol
Diclofenac may decrease the antihypertensive activities of Practolol.
Pralatrexate
The serum concentration of Pralatrexate can be increased when it is combined with Diclofenac.
Prasterone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Prasterone.
Prednicarbate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Prednicarbate.
Prednisolone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Prednisolone.
Prednisone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Prednisone.
Pregnenolone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Pregnenolone.
Primidone
The serum concentration of Diclofenac can be decreased when it is combined with Primidone.
Probenecid
The serum concentration of Diclofenac can be increased when it is combined with Probenecid.
Propranolol
Diclofenac may decrease the antihypertensive activities of Propranolol.
protein C, human
Diclofenac may increase the anticoagulant activities of Protein C.
protein S, human
Diclofenac may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Diclofenac may increase the anticoagulant activities of Protocatechualdehyde.
Pyrimethamine
The metabolism of Diclofenac can be decreased when combined with Pyrimethamine.
Quazepam
The serum concentration of Diclofenac can be increased when it is combined with Quazepam.
Quinapril
The risk or severity of adverse effects can be increased when Diclofenac is combined with Quinapril.
Quinethazone
The therapeutic efficacy of Quinethazone can be decreased when used in combination with Diclofenac.
Quinine
The metabolism of Diclofenac can be decreased when combined with Quinine.
Rabeprazole
The metabolism of Diclofenac can be decreased when combined with Rabeprazole.
Ramipril
The risk or severity of adverse effects can be increased when Diclofenac is combined with Ramipril.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Diclofenac.
Rescinnamine
The risk or severity of adverse effects can be increased when Diclofenac is combined with Rescinnamine.
Resveratrol
The risk or severity of adverse effects can be increased when Diclofenac is combined with Resveratrol.
Reviparin
Diclofenac may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Diclofenac may increase the anticoagulant activities of Reviparin.
Rifabutin
The metabolism of Diclofenac can be increased when combined with Rifabutin.
Rifampin
The serum concentration of Diclofenac can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Diclofenac can be decreased when it is combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Diclofenac.
Rimexolone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Rimexolone.
Risedronate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Risedronate.
Risedronic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Risedronate.
Rivaroxaban
Diclofenac may increase the anticoagulant activities of Rivaroxaban.
Rofecoxib
The risk or severity of adverse effects can be increased when Diclofenac is combined with Rofecoxib.
Ropinirole
The metabolism of Diclofenac can be decreased when combined with Ropinirole.
Rosiglitazone
The metabolism of Diclofenac can be decreased when combined with Rosiglitazone.
Rosoxacin
Diclofenac may increase the neuroexcitatory activities of Rosoxacin.
Rucaparib
The metabolism of Diclofenac can be decreased when combined with Rucaparib.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Diclofenac.
Salicylamide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Salicylamide.
Salicylic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Salicylic acid.
Salsalate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Salsalate.
Saquinavir
The metabolism of Diclofenac can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Diclofenac can be decreased when combined with Saquinavir.
Saralasin
The risk or severity of adverse effects can be increased when Saralasin is combined with Diclofenac.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Diclofenac.
Secobarbital
The serum concentration of Diclofenac can be decreased when it is combined with Secobarbital.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Diclofenac is combined with Serrapeptase.
Sertraline
The metabolism of Diclofenac can be decreased when combined with Sertraline.
Sildenafil
The metabolism of Diclofenac can be decreased when combined with Sildenafil.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Diclofenac.
Siltuximab
The serum concentration of Diclofenac can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Diclofenac can be increased when it is combined with Simeprevir.
Sisomicin
Diclofenac may decrease the excretion rate of Sisomicin which could result in a higher serum level.
Sodium Phosphate
Sodium phosphate may increase the nephrotoxic activities of Diclofenac.
Sodium Phosphate, Monobasic
Sodium phosphate may increase the nephrotoxic activities of Diclofenac.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Sodium phosphate may increase the nephrotoxic activities of Diclofenac.
Sorafenib
The metabolism of Diclofenac can be decreased when combined with Sorafenib.
Sotalol
Diclofenac may decrease the antihypertensive activities of Sotalol.
Sparfloxacin
Diclofenac may increase the neuroexcitatory activities of Sparfloxacin.
Spectinomycin
Diclofenac may decrease the excretion rate of Spectinomycin which could result in a higher serum level.
Spirapril
The risk or severity of adverse effects can be increased when Diclofenac is combined with Spirapril.
Spironolactone
Diclofenac may decrease the antihypertensive activities of Spironolactone.
ST. JOHN'S WORT EXTRACT
The serum concentration of Diclofenac can be decreased when it is combined with St. John's Wort.
Streptomycin
Diclofenac may decrease the excretion rate of Streptomycin which could result in a higher serum level.
Streptozocin
Diclofenac may decrease the excretion rate of Streptozocin which could result in a higher serum level.
Sulfadiazine
The serum concentration of Diclofenac can be increased when it is combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Diclofenac can be decreased when combined with Sulfamethoxazole.
Sulfasalazine
The risk or severity of adverse effects can be increased when Diclofenac is combined with Sulfasalazine.
Sulfisoxazole
The serum concentration of Diclofenac can be increased when it is combined with Sulfisoxazole.
Sulindac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Sulindac.
Suprofen
The risk or severity of adverse effects can be increased when Diclofenac is combined with Suprofen.
Tacrolimus
Diclofenac may increase the nephrotoxic activities of Tacrolimus.
Tafluprost
The therapeutic efficacy of Tafluprost can be decreased when used in combination with Diclofenac.
Talinolol
Diclofenac may decrease the antihypertensive activities of Talinolol.
Talniflumate
The risk or severity of adverse effects can be increased when Talniflumate is combined with Diclofenac.
Tamoxifen
The metabolism of Diclofenac can be decreased when combined with Tamoxifen.
Technetium Tc 99m Medronate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Technetium Tc-99m medronate.
Telaprevir
The metabolism of Diclofenac can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Diclofenac can be decreased when combined with Telithromycin.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Diclofenac.
Temafloxacin
Diclofenac may increase the neuroexcitatory activities of Temafloxacin.
Tenofovir Disoproxil
The risk or severity of adverse effects can be increased when Diclofenac is combined with Tenofovir disoproxil.
Tenoxicam
The risk or severity of adverse effects can be increased when Diclofenac is combined with Tenoxicam.
Teriflunomide
The risk or severity of adverse effects can be increased when Diclofenac is combined with Teriflunomide.
Theophylline
The metabolism of Diclofenac can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Diclofenac can be decreased when combined with Theophylline.
Thiotepa
The metabolism of Diclofenac can be decreased when combined with Thiotepa.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Tiaprofenic acid.
Ticagrelor
The metabolism of Diclofenac can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Diclofenac can be decreased when combined with Ticlopidine.
Tiludronate
The risk or severity of adverse effects can be increased when Diclofenac is combined with Tiludronic acid.
Tiludronic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Tiludronic acid.
Timolol
Diclofenac may decrease the antihypertensive activities of Timolol.
Timolol Anhydrous
Diclofenac may decrease the antihypertensive activities of Timolol.
Tixocortol
The risk or severity of adverse effects can be increased when Diclofenac is combined with Tixocortol.
Tizanidine
The serum concentration of Tizanidine can be increased when it is combined with Diclofenac.
Tobramycin
Diclofenac may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Tocilizumab
The serum concentration of Diclofenac can be decreased when it is combined with Tocilizumab.
Tolbutamide
The serum concentration of Diclofenac can be increased when it is combined with Tolbutamide.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Tolfenamic Acid.
Tolmetin
The risk or severity of adverse effects can be increased when Diclofenac is combined with Tolmetin.
Topiramate
The metabolism of Diclofenac can be decreased when combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Diclofenac.
Torsemide
The therapeutic efficacy of Torasemide can be decreased when used in combination with Diclofenac.
Trandolapril
The risk or severity of adverse effects can be increased when Diclofenac is combined with Trandolapril.
Tranilast
The risk or severity of adverse effects can be increased when Diclofenac is combined with Tranilast.
Tranylcypromine
The metabolism of Diclofenac can be decreased when combined with Tranylcypromine.
Travoprost
The therapeutic efficacy of Travoprost can be decreased when used in combination with Diclofenac.
Treprostinil
The risk or severity of adverse effects can be increased when Treprostinil is combined with Diclofenac.
Triamcinolone
The risk or severity of adverse effects can be increased when Diclofenac is combined with Triamcinolone.
Triamterene
Diclofenac may decrease the antihypertensive activities of Triamterene.
Trichlormethiazide
The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Diclofenac.
Trimethoprim
The metabolism of Diclofenac can be decreased when combined with Trimethoprim.
Trovafloxacin
Diclofenac may increase the neuroexcitatory activities of Trovafloxacin.
Troxerutin
Diclofenac may increase the anticoagulant activities of Troxerutin.
UNOPROSTONE
The therapeutic efficacy of Unoprostone can be decreased when used in combination with Diclofenac.
Valdecoxib
The risk or severity of adverse effects can be increased when Diclofenac is combined with Valdecoxib.
Valproate
The metabolism of Diclofenac can be decreased when combined with Valproic Acid.
Valproic Acid
The metabolism of Diclofenac can be decreased when combined with Valproic Acid.
Valrubicin
Diclofenac may decrease the excretion rate of Valrubicin which could result in a higher serum level.
Valsartan
The metabolism of Diclofenac can be decreased when combined with Valsartan.
Vancomycin
The serum concentration of Vancomycin can be increased when it is combined with Diclofenac.
Vemurafenib
The serum concentration of Diclofenac can be increased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Diclofenac can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Diclofenac can be decreased when combined with Verapamil.
Vincristine
The excretion of Vincristine can be decreased when combined with Diclofenac.
Voriconazole
The serum concentration of Diclofenac can be increased when it is combined with Voriconazole.
Warfarin
Diclofenac may increase the anticoagulant activities of Warfarin.
Zafirlukast
The metabolism of Diclofenac can be decreased when combined with Zafirlukast.
Zileuton
The risk or severity of adverse effects can be increased when Diclofenac is combined with Zileuton.
Ziprasidone
The metabolism of Diclofenac can be decreased when combined with Ziprasidone.
Zofenopril
The risk or severity of adverse effects can be increased when Diclofenac is combined with Zofenopril.
Zoledronic Acid
The risk or severity of adverse effects can be increased when Diclofenac is combined with Zoledronic acid.
Zoledronic Acid Anhydrous
The risk or severity of adverse effects can be increased when Diclofenac is combined with Zoledronic acid.
Zomepirac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Zomepirac.
